Reduced high-molecular-weight adiponectin is an independent risk factor for cardiovascular lesions in hypercholesterolaemic patients

Clinical Endocrinology

Volumn 78, Issue 4, 2013, Pages 539-544

  Wang, Wenqing ^a   Xing, Wenjuan ^b   Zhang, Haifeng ^b   Ding, Mingge ^c   Shang, Lei ^b   Lau, Wayne Bond ^d   Wang, Xiaoming ^c   Li, Rong ^c  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ADIPONECTIN; C REACTIVE PROTEIN; CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH MOLECULAR WEIGHT ADIPONECTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; URIC ACID;

ADULT; AGED; AGING; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; HORMONE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; OBESITY; PRIORITY JOURNAL; URIC ACID BLOOD LEVEL;

ADIPONECTIN; ADULT; AGED; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DOWN-REGULATION; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; MOLECULAR WEIGHT; OSMOLAR CONCENTRATION; PROTEIN MULTIMERIZATION; RISK FACTORS;

EID: 84875165330     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04444.x     Document Type: Article

References (35)

1. Scherer, P.E., Williams, S., Fogliano, M., et al,. (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. Journal of Biological Chemistry 270, 26746-26749.
2. Pajvani, U.B., Du, X., Combs, T.P., et al,. (2003) Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. Journal of Biological Chemistry 278, 9073-9085.
3. Waki, H., Yamauchi, T., Kamon, J., et al,. (2003) Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. Journal of Biological Chemistry 278, 40352-40363.
4. Zhu, W., Cheng, K.K., Vanhoutte, P.M., et al,. (2008) Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. Clinical Science (London) 114, 361-374.
5. Goldstein, B.J., Scalia, R.G., &, Ma, X.L., (2009) Protective vascular and myocardial effects of adiponectin. Nature Clinical Practice Cardiovascular Medicine 6, 27-35.
6. Rabin, K.R., Kamari, Y., Avni, I., et al,. (2005) Adiponectin: linking the metabolic syndrome to its cardiovascular consequences. Expert Review of Cardiovascular Therapy 3, 465-471.
7. Kumada, M., Kihara, S., Sumitsuji, S., et al,. (2003) Association of hypoadiponectinemia with coronary artery disease in men. Arteriosclerosis, Thrombosis, and Vascular Biology 23, 85-89.
8. Hotta, K., Funahashi, T., Arita, Y., et al,. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis, Thrombosis, and Vascular Biology 20, 1595-1599.
9. Semple, R.K., Halberg, N.H., Burling, K., et al,. (2007) Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies. Diabetes 56, 1712-1717.
10. Kanety, H., Hemi, R., Ginsberg, S., et al,. (2009) Total and high molecular weight adiponectin are elevated in patients with Laron syndrome despite marked obesity. European Journal of Endocrinology 161, 837-844.
11. Rodriguez, A., Catalan, V., Becerril, S., et al,. (2008) Impaired adiponectin-AMPK signalling in insulin-sensitive tissues of hypertensive rats. Life Sciences 83, 540-549.
12. Li, R., Xu, M., Wang, X., et al,. (2010) Reduced vascular responsiveness to adiponectin in hyperlipidemic rats-mechanisms and significance. Journal of Molecular and Cellular Cardiology 49, 508-515.
13. Rizza, S., Gigli, F., Galli, A., et al,. (2010) Adiponectin isoforms in elderly patients with or without coronary artery disease. Journal of the American Geriatrics Society 58, 702-706.
14. Martos-Moreno, G.A., Barrios, V., Martinez, G., et al,. (2010) Effect of weight loss on high-molecular weight adiponectin in obese children. Obesity (Silver Spring) 18, 2288-2294.
15. Satoh, H., Fujii, S., &, Tsutsui, H., (2010) The high-molecular weight (HMW) form of adiponectin is a significant surrogate marker for the prediction of type 2 diabetes mellitus in the Japanese population. Nutrition, Metabolism and Cardiovascular Diseases 20, e9-e10.
16. China Initiative on Clinical Control of Dyslipidemia Expert Group. [Expert recommendations on attaining the goal for treatment of hypercholesterolemia in clinical practice]. Zhonghua Xin Xue Guan Bing Za Zhi 38, 294-298.
17. Kadowaki, T., Yamauchi, T., Kubota, N., et al,. (2006) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. Journal of Clinical Investigation 116, 1784-1792.
18. Bruce, C.R., Mertz, V.A., Heigenhauser, G.J., et al,. (2005) The stimulatory effect of globular adiponectin on insulin-stimulated glucose uptake and fatty acid oxidation is impaired in skeletal muscle from obese subjects. Diabetes 54, 3154-3160.
19. Chen, M.B., McAinch, A.J., Macaulay, S.L., et al,. (2005) Impaired activation of AMP-kinase and fatty acid oxidation by globular adiponectin in cultured human skeletal muscle of obese type 2 diabetics. Journal of Clinical Endocrinology and Metabolism 90, 3665-3672.
20. Mullen, K.L., Smith, A.C., Junkin, K.A., et al,. (2007) Globular adiponectin resistance develops independently of impaired insulin-stimulated glucose transport in soleus muscle from high-fat-fed rats. American Journal of Physiology. Endocrinology and Metabolism 293, E83-E90.
21. Mullen, K.L., Pritchard, J., Ritchie, I., et al,. (2009) Adiponectin resistance precedes the accumulation of skeletal muscle lipids and insulin resistance in high-fat-fed rats. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology 296, R243-R251.
22. Wang, Y., Lam, K.S., Yau, M.H., et al,. (2008) Post-translational modifications of adiponectin: mechanisms and functional implications. The Biochemistry Journal 409, 623-633.
23. Wang, Z.V., Schraw, T.D., Kim, J.Y., et al,. (2007) Secretion of the adipocyte-specific secretory protein adiponectin critically depends on thiol-mediated protein retention. Molecular and Cellular Biology 27, 3716-3731.
24. Koenen, T.B., van Tits, L.J., Holewijn, S., et al,. (2008) Adiponectin multimer distribution in patients with familial combined hyperlipidemia. Biochemical and Biophysical Research Communications 376, 164-168.
25. Lau, W.B., Tao, L., Wang, Y., et al,. (2011) Systemic adiponectin malfunction as a risk factor for cardiovascular disease. Antioxidants & Redox Signaling 15, 1863-1873.
26. Bik, W., Baranowska-Bik, A., Wolinska-Witort, E., et al,. (2006) The relationship between adiponectin levels and metabolic status in centenarian, early elderly, young and obese women. Neuro Endocrinology Letters 27, 493-500.
27. Adamczak, M., Rzepka, E., Chudek, J., et al,. (2005) Ageing and plasma adiponectin concentration in apparently healthy males and females. Clinical Endocrinology (Oxford) 62, 114-118.
28. Stenvinkel, P., Marchlewska, A., Pecoits-Filho, R., et al,. (2004) Adiponectin in renal disease: relationship to phenotype and genetic variation in the gene encoding adiponectin. Kidney International 65, 274-281.
29. Saraheimo, M., Forsblom, C., Fagerudd, J., et al,. (2005) Serum adiponectin is increased in type 1 diabetic patients with nephropathy. Diabetes Care 28, 1410-1414.
30. Baldwin, W., McRae, S., Marek, G., et al,. (2011) Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes 60, 1258-1269.
31. Lara-Castro, C., Luo, N., Wallace, P., et al,. (2006) Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 55, 249-259.
32. Bobbert, T., Rochlitz, H., Wegewitz, U., et al,. (2005) Changes of adiponectin oligomer composition by moderate weight reduction. Diabetes 54, 2712-2719.
33. Aso, Y., Yamamoto, R., Suetsugu, M., et al,. (2007) Comparison of the effects of pioglitazone and voglibose on circulating total and high-molecular-weight adiponectin, and on two fibrinolysis inhibitors, in patients with Type 2 diabetes. Diabetic Medicine 24, 962-968.
34. Pischon, T., Girman, C.J., Hotamisligil, G.S., et al,. (2004) Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291, 1730-1737.
35. Blüher, M., Bullen Jr, J.W., Lee, J.H., et al,. (2006) Circulating adiponectin and expression of adiponectin receptors in human skeletal muscle: associations with metabolic parameters and insulin resistance and regulation by physical training. Journal of Clinical Endocrinology and Metabolism 91, 2310-2316.